Related Experiment Video
Updated: Aug 9, 2025
08:56
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
5.5K
Global or local: The future of biotech
Vincent Tse1, Liang Schweizer1
1HiFiBiO Therapeutics, 237 Putnam Avenue, Cambridge, MA 02139, USA.
Drug Discovery Today
|February 16, 2023
Summary
Born-global biotechnology (biotech) startups, by accessing global resources and talent early, are better positioned for success. This approach addresses innovation, resource, and talent challenges for faster growth.
Area of Science:
- Biotechnology
- Pharmaceutical Sciences
- Entrepreneurship
Background:
- Biotech startups traditionally focus domestically, limiting access to resources and talent.
- Developing novel therapeutics demands substantial investment and long-term commitment.
- Current industry challenges necessitate innovative strategies for growth and success.
Purpose of the Study:
- To advocate for the 'born-global' approach in biotechnology startups.
- To demonstrate how born-global biotechs can overcome industry challenges.
- To provide a framework for achieving success as a born-global biotech.
Main Methods:
- Comparative analysis of domestic vs. born-global biotech models.
- Literature review on innovation, resource management, and talent acquisition in biotech.
- Development of an operational framework based on the FlyWheel concept.
Main Results:
- Born-global biotechs exhibit enhanced capacity to address innovation and resource constraints.
- Global access mitigates limitations in talent diversity.
- Capital efficiency is crucial for maximizing born-global advantages.
Conclusions:
- Adopting a born-global strategy is advantageous for biotech startup success.
- The FlyWheel concept offers a practical operational model for born-global biotechs.
- Early global integration is key to navigating complex therapeutic development landscapes.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
106
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
106
01:20The Central Dogma
23.1K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
23.1K
01:29Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
01:59Plant Breeding and Biotechnology
19.5K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
19.5K
01:31Hybridoma Technology
15.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.1K
01:09Recombinant DNA
96.1K
Overview
96.1K